Loblaw Companies Limited

Research Loblaw Companies Limited (L8G) on Bullrun: valuation model: 8.1% overvalued, market cap EUR 45.39B, P/E 28.5, dividend yield 1.0%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

Bullrun's latest valuation model marks Loblaw Companies Limited as 8.1% overvalued; latest market cap is EUR 45.39B; P/E is 28.5; dividend yield is 1.0%.

About Loblaw Companies Limited

Loblaw Companies Limited, a food and pharmacy company, provides grocery, pharmacy and healthcare services, health and beauty products, apparel, general merchandise, financial services, and wireless mobile products and services in Canada and the United States. It operates through two segments, Retail and Financial Services. The Retail segment operates corporate and franchise-owned retail food, and associate-owned drug stores.

Frequently asked questions

Is Loblaw Companies Limited overvalued or undervalued?

Bullrun's valuation model currently marks Loblaw Companies Limited as 8.1% overvalued.

What is Loblaw Companies Limited's market cap?

Loblaw Companies Limited's market capitalization is EUR 45.39B.

What is Loblaw Companies Limited's P/E ratio?

Loblaw Companies Limited's price-to-earnings (P/E) ratio is 28.5.

Does Loblaw Companies Limited pay a dividend?

Loblaw Companies Limited has a dividend yield of 1.0%.

What does Loblaw Companies Limited do?

Loblaw Companies Limited, a food and pharmacy company, provides grocery, pharmacy and healthcare services, health and beauty products, apparel, general merchandise, financial services, and wireless mobile products and services in Canada and the United States.